SG Americas Securities
AGTC

SG Americas Securities’s Applied Genetic Technologies Corporation AGTC Stock Holding History

SG Americas Securities’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,593
Closed -$70K – 3692
2020
Q2 		$70K Buy
+12,593
New +$57.7K ﹤0.01% 3470

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities's AGTC Position: Q3 2020 in Review

SG Americas Securities sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2020, closing a stake of 12,593 shares — an estimated $70K sold.

SG Americas Securities first reported a position in AGTC in Q2 2020 and held it in 1 quarter. The position peaked at $70K in Q2 2020. 71 funds tracked by Wall St. Rank hold AGTC as of Q3 2020.

  • SG Americas Securities reported no remaining Applied Genetic Technologies Corporation position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 12,593 Applied Genetic Technologies Corporation shares in Q3 2020, an estimated $70K.
  • SG Americas Securities first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 1 quarter.
  • SG Americas Securities's Applied Genetic Technologies Corporation position peaked at $70K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.